Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Quantin

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2010
Time to diagnosis of lung cancer: technical and pyschological factors that slow down diagnostic and treatment timelinesJean Louis Pujol, Xavier Quantin
Journal of Palliative Care|July 24, 2015
Barriers to, and Facilitators of Physical Activity in Patients Receiving Chemotherapy for Lung Cancer: An exploratory studySébastien Mas, Xavier Quantin, Grégory Ninot
Biomolecules|November 2, 2019
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and ManagementIsabelle Solassol, Frédéric Pinguet, Xavier Quantin
The American Journal on Addictions|April 14, 2015
Self-reported physical activity in smoking pre-cessation is not a protective factor against relapse for allPaquito Bernard, Gregory Ninot, Xavier Quantin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2009
Cardiorespiratory fitness in patients with advanced non-small cell lung cancer: why is this feature important to evaluate? Can it be improved?Jean Louis Pujol, Xavier Quantin, Mohammad Chakra
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Recursive Partitioning Analysis Groups II-III brain metastases of non-small cell lung cancer: a phase II randomized study comparing two concurrent chemoradiotherapy regimensXavier Quantin, Marie Cécile Bozonnat, Jean-Louis Pujol
Therapeutic Advances in Medical Oncology|January 8, 2021
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatmentJulie A Vendrell, Xavier Quantin, Isabelle Serre, et al.
Clinical Case Reports|May 24, 2021
Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case reportQuentin Dominique Thomas, Léa Sinoquet, Antonio Maraver, et al.
Bulletin Du Cancer|November 27, 2002
[Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?]Jean-Louis Pujol, Didier Choma, William Jacot, et al.
Clinical Chemistry|November 2, 2022
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung CancerLéa Sinoquet, William Jacot, Xavier Quantin, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2010
Time to diagnosis of lung cancer: technical and pyschological factors that slow down diagnostic and treatment timelinesJean Louis Pujol, Xavier Quantin
Journal of Palliative Care|July 24, 2015
Barriers to, and Facilitators of Physical Activity in Patients Receiving Chemotherapy for Lung Cancer: An exploratory studySébastien Mas, Xavier Quantin, Grégory Ninot
Biomolecules|November 2, 2019
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and ManagementIsabelle Solassol, Frédéric Pinguet, Xavier Quantin
The American Journal on Addictions|April 14, 2015
Self-reported physical activity in smoking pre-cessation is not a protective factor against relapse for allPaquito Bernard, Gregory Ninot, Xavier Quantin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2009
Cardiorespiratory fitness in patients with advanced non-small cell lung cancer: why is this feature important to evaluate? Can it be improved?Jean Louis Pujol, Xavier Quantin, Mohammad Chakra
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Recursive Partitioning Analysis Groups II-III brain metastases of non-small cell lung cancer: a phase II randomized study comparing two concurrent chemoradiotherapy regimensXavier Quantin, Marie Cécile Bozonnat, Jean-Louis Pujol
Therapeutic Advances in Medical Oncology|January 8, 2021
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatmentJulie A Vendrell, Xavier Quantin, Isabelle Serre, et al.
Clinical Case Reports|May 24, 2021
Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case reportQuentin Dominique Thomas, Léa Sinoquet, Antonio Maraver, et al.
Bulletin Du Cancer|November 27, 2002
[Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?]Jean-Louis Pujol, Didier Choma, William Jacot, et al.
Clinical Chemistry|November 2, 2022
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung CancerLéa Sinoquet, William Jacot, Xavier Quantin, et al.
Pageof 9